Innocare Pharma Ltd (INCPF) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Innocare Pharma Ltd. Class A.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.330 -- 00:00:04.192 Good morning and good evening to our global investors. 00:00:04.192 -- 00:00:09.176 Thank you for joining InnoCare Pharma 2026 Entrant Results. 00:00:09.176 -- 00:00:14.073 This is Li Chenfeng from China Healthcare from Goldman Sachs. 00:00:14.073 -- 00:00:17.815 We saw today an InnoCare management team including Dr. 00:00:17.815 -- 00:00:22.957 Jasmine Cui, the chairlady and CEO, Dr. Xiangyang Chen, the CTO, 00:00:22.957 -- 00:00:28.399 Mr. Xinfu, CFO, Dr. Renbing Zhao, Senior VP of Clinical Development, 00:00:28.399 -- 00:00:31.961 Dr. Carrie Zhou, VP of Medical Research, Dr. 00:00:31.961 -- 00:00:35.302 Jason Jiang, VP of Translational Research, and Ms. 00:00:35.302 -- 00:00:40.419 Bonnie Yuan, Senior Director of IR. Before we kick off the session, I would 00:00:40.419 -- 00:00:44.605 like to highlight that this call is strictly for clients of Goldman Sachs and anal care 00:00:44.605 -- 00:00:49.622 only, and this conversation is not intended for the media and is off the record. 00:00:49.622 -- 00:00:54.406 Participants will be removed from the call if they cannot be properly identified. 00:00:54.406 -- 00:00:58.629 And this call is not for the purpose of sharing or receiving the public or otherwise 00:00:58.629 -- 00:01:03.552 confidential information. Attendees are public side market participants who may not receive 00:01:03.552 -- 00:01:08.096 and should not request non-public otherwise confidential information about issuers or 00:01:08.096 -- 00:01:11.078 securities or about the market of securities. 00:01:11.078 -- 00:01:16.761 And okay, I just put out the results a couple of hours ago. 00:01:17.020 -- 00:01:21.263 And today we're going to have the management team to discuss the business updates and 00:01:21.263 -- 00:01:27...